News
-
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
-
Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
-
Solitario CEO to Present at John Tumazos Very Independent Research, LLC
-
Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
-
GameSquare to Present at Upcoming Investor Conferences
-
Vedere Holdings PLC Annual Report
-
PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 septembre 2026 au 02 octobre 2026
-
Director/PDMR Shareholding
-
init is entering the market for the management of autonomous fleets through a stake in successful Norwegian start-up
-
2CRSi SA: Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
-
Disclosure of shares outstanding and voting rights - 05.10.2026
-
Déclaration nombre d'actions et droits de vote - 05.10.2026
-
LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
-
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
-
Declaration of voting rights at the end of September 2026